Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils

British Journal of Pharmacology

Volumn 121, Issue 1, 1997, Pages 77-82

  Teixeira, Mauro M ^a   Al Rashed, Sabah ^a   Rossi, Adriano G ^a,b   Hellewell, Paul G ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Aggregation; Cyclic AMP; Eosinophils; Prostaglandins; Prostanoid receptors

Indexed keywords

2 [4 (1 HYDROXYHEXYL)PHENYL] 5 OXOCYCLOPENTANEHEPTANOIC ACID; 3 BENZYL 5 (6 CARBOXYHEXYL) 1 (2 CYCLOHEXYL 2 HYDROXYETHYLAMINO)HYDANTOIN; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; BUTAPROST; CICAPROST; ILOPROST; KT 5720; MISOPROSTOL; PROSTAGLANDIN D2; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTANOID RECEPTOR; SULPROSTONE; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG POTENCY; EOSINOPHIL; GUINEA PIG; LEUKOCYTE AGGREGATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030899268     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701107     Document Type: Article

References (21)

1. BUTCHERS, P.R. & VARDEY, C.J. (1990). The effect of prostanoids on the function of human eosinophils. Agents Actions, S31, 103 - 112.
2. BUTTERFIELD, J.H. & LEIFERMAN, K.M. (1993). Eosinophil-associated diseases. In Immunopharmacology of Eosinophils. ed. Smith, H. & Cook, R.M. pp. 152 - 192. London: Academic Press.
3. COLEMAN, R.A., GRIX, S.P., HEAD, S.A., LOUTTIT, J.B., MALLET, A. & SHELDRICK, R.L.G. (1994a). A novel inhibitory receptor in piglet saphenous vein. Prostaglandins, 47, 151 - 168.
4. COLEMAN, R.A., SMITH, W.L. & NARUMIYA, S. (1994b). VIII. International union of pharmacology classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacol. Rev., 46, 205 - 229.
5. DJUKANOVIC, R., ROCHE, W.R., WILSON, J.W., BEASLEY, C.R.W., TWENTYMAN, O.P., HOWARTH, P.H. & HOLGATE, S.T. (1990). Mucosal inflammation in asthma. Am. Rev. Respir. Dis., 142, 434 - 457.
6. GLEICH, G.J. ADOLPHSON, C.R. & LEIFERMAN, K.M. (1993). The biology of the eosinophilic leukocyte. Ann. Rev. Med. 44, 85 - 101.
7. HIRATA, M., KAKIZUKA, A., AIZAWA, M., USHIKUBI, S. & NARUMIYA, S. (1994). Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc. Natl. Acad. Sci. U.S.A., 91, 11192 - 11196.
8. 3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase. Eur. J. Biochem., 217, 313 - 318.
9. IRIE, K., TOKUDA, H., HAGIWARA, K., HAYASHI, H. MURAO, S. & ITO, Y. (1985). Structure-activity relationship in the induction of Epstein-Barr virus by teleocidin derivatives. Int. J. Cancer, 36, 485 - 488.
10. MCLAREN, D.J. (1980). Schistosoma mansoni: the Parasite Surface in Relation to Host Immunity, Chichester, U.K.: Research Studies Press.
11. MEURER, R., VAN RIPER, G., FEENEY, W., CUNNINGHAM, P., HORA, D., SPRINGER, M.S., MACINTYRE, D.E. & ROSEN, H. (1993). Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1α, or human interleukin 8. J. Exp. Med., 178, 1913 - 1921.
12. PIERCE, K.L., GIL, D.W., WOODWARD, D.F. & REGAN, J.W. (1995). Cloning of human prostanoid receptors. Trends Pharmacol. Sci., 16, 153 - 256.
13. 2 and histamine activate human eosinophils. J. Immunol., 148, 3536 - 3542.
14. ROSSI, A.G. & O'FLAHERTY, J.T. (1989). Prostaglandin binding sites in human polymorphonuclear neutrophils. Prostaglandins, 37, 641 - 653.
15. TALPAIN, E., ARMSTRONG, R.A., COLEMAN, R.A. & VARDEY, C.J. (1995). Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils. Br. J. Pharmacol., 114, 1459 - 1465.
16. TEIXEIRA, M.M., ROSSI, A.G., GIEMBYCZ, M.A. & HELLEWELL, P.G. (1996a). Effects of agents which elevate cyclic AMP on eosinophil homotypic aggregation. Br. J. Pharmacol., 118, 2099 - 2106.
17. TEIXEIRA, M.M., ROSSI, A.G. & HELLEWELL, P.G. (1996b). Adhesion mechanisms involved in C5a-induced eosinophil homotypic aggregation. J. Leukocyte Biol., 59, 389 - 396.
18. TEIXEIRA, M.M., WILLIAMS, T.J., AU, B-T., HELLEWELL, P.G. & ROSSI, A.G. (1995). Characterisation of eosinophil homotypic aggregation. J. Leukocyte Biol., 57, 226 - 234.
19. 1 subtype of prostaglandin E receptor. J. Biol. Chem. 268, 20175 - 20178.
20. WHEELDON, A. & VARDEY, C.J. (1993). Characterization of the inhibitory prostanoid receptors on human neutrophils. Br. J. Pharmacol., 108, 1051 - 1054.
21. WISE, H. & JONES, R.L. (1994). Characterization of prostanoid receptors on rat neutrophils. Br. J. Pharmacol., 113, 581 - 587.